Timetable
Subject to change
Wednesday, 11 September, 2024 |
||
Hall A – Pentland | Hall B – Sidlaw | |
12:00-13:00 | Industry Lunch Symposium | Industry Lunch Symposium |
13:00-13:15 | Congress Opening | |
13:15-14:45 | Session 1: Neoadjuvant therapy |
|
14:40-15:10 | Coffee break | |
15:10-16:10 | Session 2: Imaging |
Session 3: HER2+ve disease |
16:10-17:10 | Session 4: DCIS |
Session 5: Metastatic HR+ve breast disease |
17:15-18:15 | Networking Reception |
Thursday, 12 September, 2024 |
||
Hall A – Pentland | Hall B – Sidlaw | |
07:00-08:30 | Industry Breakfast Symposium | Industry Breakfast Symposium |
08:30-09:30 | Session 6: Breast cancer in young women |
|
09:30-11:00 | Session 7: Screening |
Session 8: Triple negative breast cancer |
11:00-11:30 | Coffee break and poster viewing | |
11:30-12:30 | Session 9: Metastatic Breast Cancer (MBC) |
Session 10: Free Papers: Surgical |
12:30-13:30 | Pre-lunch Industry Symposium: | Pre-lunch Industry Symposium: |
13:30-14:30 | Lunch break and poster viewing | |
14:30-15:30 | Session 11: Genetics |
Session 12: Free Papers: Medical oncology |
15:30-16:00 | Coffee break and poster viewing | |
16:00-17:30 | Session 13: Adjuvant endocrine therapy |
Friday, 13 September, 2024 |
||
Hall A – Pentland | Hall B – Sidlaw | |
07:00-08:30 | Industry Breakfast Symposium | Industry Breakfast Symposium |
08:30-10:00 | Session 14: Reconstruction |
Session 15: Supportive care |
10:00-10:30 | Coffee break and poster viewing | |
10:30-11:30 | Session 16: Locoregional management |
|
11:30-12:30 | Session 17: Breast cancer 2035 |
|
12:30-12:45 | Congress closing and award presentation |